Oder Investment Management’s AbbVie ABBV Stock Holding History

Oder Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$790K	Buy	3,634 +73	+2%	+$16.2K	0.61%	44
2025 Q4	$814K	Sell	3,561 -278	-7%	-$63.3K	0.59%	45
2025 Q3	$889K	Buy	3,839 +21	+0.6%	+$4.28K	0.64%	44
2025 Q2	$709K	Sell	3,818 -97	-2%	-$18K	0.54%	47
2025 Q1	$820K	Sell	3,915 -190	-5%	-$36.9K	0.7%	42
2024 Q4	$729K	Sell	4,105 -219	-5%	-$40.3K	0.61%	47
2024 Q3	$854K	Sell	4,324 -122	-3%	-$22.8K	0.73%	44
2024 Q2	$763K	Sell	4,446 -91	-2%	-$15.1K	0.69%	49
2024 Q1	$826K	Sell	4,537 -508	-10%	-$87.5K	0.77%	43
2023 Q4	$782K	Buy	5,045 +3	+0.1%	+$437	0.77%	40
2023 Q3	$752K	Buy	5,042 +16	+0.3%	+$2.35K	0.81%	34
2023 Q2	$677K	Buy	5,026 +188	+4%	+$27.6K	0.74%	44
2023 Q1	$771K	Sell	4,838 -99	-2%	-$15.1K	0.9%	34
2022 Q4	$798K	Sell	4,937 -56	-1%	-$8.59K	0.99%	29
2022 Q3	$670K	Sell	4,993 -136	-3%	-$19.5K	0.79%	42
2022 Q2	$785K	Buy	+5,129	New	+$784K	0.97%	31
2021 Q3	–	Sell	-6,792	Closed	-$765K	–	81
2021 Q2	$765K	Buy	6,792 +273	+4%	+$30.7K	1%	25
2021 Q1	$706K	Buy	6,519 +2,410	+59%	+$258K	0.97%	27
2020 Q4	$436K	Buy	+4,109	New	+$395K	0.43%	57

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Oder Investment Management's ABBV Position: Q1 2026 in Review

Oder Investment Management increased its AbbVie (ABBV) stake by 2% in Q1 2026, buying an estimated $16.2K and bringing the position to 3,634 shares worth $790K. The position accounts for 0.61% of the portfolio, ranked #44.

Oder Investment Management first reported a position in ABBV in Q4 2020 and has held it in 19 quarters since. The position peaked at $889K in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Oder Investment Management held 3,634 shares of AbbVie worth $790K as of Q1 2026.
Oder Investment Management bought 73 AbbVie shares in Q1 2026, an estimated $16.2K.
AbbVie made up 0.61% of Oder Investment Management's portfolio in Q1 2026, its #44 holding.
Oder Investment Management first reported a position in AbbVie in Q4 2020 and has held it in 19 quarters since.
Oder Investment Management's AbbVie position peaked at $889K in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Oder Investment Management's 13F filing for Q1 2026, filed 5 May 2026.